New hope for ulcerative colitis: experimental drug OD-07656 enters Mid-Stage trial
Disease control
Recruiting now
This study tests a new drug called OD-07656 in people with moderate to severe ulcerative colitis, a chronic bowel disease. The goal is to see if it safely reduces symptoms like bleeding and diarrhea, and if it can make a follow-up treatment (vedolizumab) work better. About 57 adu…
Phase: PHASE2 • Sponsor: Odyssey Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC